Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.71222 | 30 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.66436 | 29 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.69433 | 30 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.80796 | 38 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.28806 | 54 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.71719 | 28 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.78699 | 32 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.67355 | 30 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.67516 | 31 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.69047 | 31 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.57282 | 25 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.67808 | 31 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.65758 | 29 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.68208 | 30 |